Tech Company Financing Transactions
Allinaire Funding Round
BioCrossroads, Innovate Indiana Fund and private investors participated in a funding round for Allinaire. The round closed on 1/30/2017.
Transaction Overview
Company Name
Announced On
1/30/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
BioCrossroads (David Johnson)
Innovate Indiana Fund (Ken Green)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20600 Chagrin Blvd. 210
Cleveland, OH 44122
USA
Cleveland, OH 44122
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by scientific founders Irina Petrache, MD, and Matthias Clauss, PhD of a novel therapeutic target that plays a central role in the development and progression of lung disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Wade Lange
Browse more venture capital transactions:
Prev: 1/30/2017: Simr venture capital transaction
Next: 1/30/2017: Mardil Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs